Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 5 studies | 24% ± 6% | |
| epithelial cell | 5 studies | 27% ± 9% | |
| conventional dendritic cell | 3 studies | 27% ± 10% | |
| erythrocyte | 3 studies | 43% ± 12% | |
| erythroblast | 3 studies | 38% ± 24% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 3 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 100% | 4930.95 | 21 / 21 | 100% | 82.20 | 504 / 504 |
| esophagus | 100% | 4518.49 | 1445 / 1445 | 100% | 87.58 | 183 / 183 |
| intestine | 100% | 4972.05 | 966 / 966 | 100% | 92.57 | 527 / 527 |
| lung | 100% | 4968.15 | 578 / 578 | 100% | 72.90 | 1155 / 1155 |
| ovary | 100% | 4056.87 | 180 / 180 | 100% | 62.47 | 430 / 430 |
| skin | 100% | 4127.01 | 1809 / 1809 | 100% | 68.31 | 472 / 472 |
| stomach | 100% | 3758.11 | 359 / 359 | 100% | 83.60 | 286 / 286 |
| prostate | 100% | 4984.73 | 245 / 245 | 100% | 44.83 | 501 / 502 |
| uterus | 100% | 5113.29 | 170 / 170 | 100% | 74.36 | 458 / 459 |
| thymus | 100% | 4912.61 | 653 / 653 | 100% | 54.24 | 603 / 605 |
| adrenal gland | 100% | 4435.35 | 258 / 258 | 100% | 57.34 | 229 / 230 |
| kidney | 100% | 3871.90 | 89 / 89 | 100% | 47.31 | 897 / 901 |
| breast | 100% | 4551.53 | 459 / 459 | 99% | 44.61 | 1110 / 1118 |
| pancreas | 100% | 2398.96 | 327 / 328 | 99% | 62.93 | 177 / 178 |
| brain | 99% | 2418.67 | 2607 / 2642 | 100% | 48.16 | 705 / 705 |
| liver | 100% | 2124.90 | 226 / 226 | 95% | 29.28 | 387 / 406 |
| adipose | 100% | 4588.96 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 101.51 | 29 / 29 |
| spleen | 100% | 6418.20 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 65.01 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 44.88 | 1 / 1 |
| blood vessel | 100% | 3799.09 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 100% | 4572.01 | 928 / 929 | 0% | 0 | 0 / 0 |
| muscle | 100% | 3166.61 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 100% | 2678.63 | 859 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 45.32 | 79 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0009887 | Biological process | animal organ morphogenesis |
| GO_0044458 | Biological process | motile cilium assembly |
| GO_0006884 | Biological process | cell volume homeostasis |
| GO_1903251 | Biological process | multi-ciliated epithelial cell differentiation |
| GO_0008015 | Biological process | blood circulation |
| GO_0098534 | Biological process | centriole assembly |
| GO_0042127 | Biological process | regulation of cell population proliferation |
| GO_0002064 | Biological process | epithelial cell development |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0003677 | Molecular function | DNA binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_1990841 | Molecular function | promoter-specific chromatin binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0019904 | Molecular function | protein domain specific binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0001216 | Molecular function | DNA-binding transcription activator activity |
| GO_0046983 | Molecular function | protein dimerization activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | E2F4 |
| Protein name | Transcription factor E2F4 (E2F-4) E2F transcription factor 4 |
| Synonyms | |
| Description | FUNCTION: Transcription activator that binds DNA cooperatively with DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. The DRTF1/E2F complex functions in the control of cell-cycle progression from G1 to S phase. E2F4 binds with high affinity to RBL1 and RBL2. In some instances can also bind RB1. Specifically required for multiciliate cell differentiation: together with MCIDAS and E2F5, binds and activate genes required for centriole biogenesis. . |
| Accessions | ENST00000379378.8 H3BTM3 Q16254 ENST00000565849.5 H3BMP3 ENST00000569573.1 I3L1B6 ENST00000565226.1 ENST00000568839.5 H3BVE4 |